The Comptroller General of Medicines of India (DCGI) has granted permission to the Pune Serum Institute of India (SII) to resume its phase two and three clinical trials of the Oxford Covid-19 candidate vaccine in the country. DCGI VG Somani, in a letter to SII, has said that the institute’s …
Read More »Serum Institute Receives Authorization to Resume Oxford Covid-19 Vaccine Trial in India
